Adamis Pharmaceuticals (United States)

Adamis Pharmaceuticals Corporation is a specialty pharmaceutical company developing and commercializing products in allergy, respiratory disease, and opioid overdose treatment. Based in San Diego, California, Adamis manufactures Symjepi (epinephrine injection) for severe allergic reactions and anaphylaxis, and ZIMHI (naloxone injection) for opioid overdose emergency treatment. The company focuses on affordable, accessible treatments for life-threatening conditions.